{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:18:40Z","timestamp":1767212320227,"version":"3.41.2"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02857-w","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:42:22Z","timestamp":1752136942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring co-infection dynamics and immune response interactions between COVID-19 and Monkeypox: implications for disease severity, viral transmission, and vaccine efficacy"],"prefix":"10.1186","volume":"22","author":[{"given":"Oluwatoyin","family":"Ayo-Farai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nenrot","family":"Gopep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aminat","family":"Alarape-Raji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rida","family":"Arif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisha","family":"Kashif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik Olatunde","family":"Oduoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Usman","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"4","key":"2857_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","volume":"87","author":"T Singhal","year":"2020","unstructured":"Singhal T. A review of coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281\u20136. https:\/\/doi.org\/10.1007\/s12098-020-03263-6.","journal-title":"Indian J Pediatr"},{"key":"2857_CR2","unstructured":"Moore S. History of COVID-19. News-Medical. September 20, 2021. Accessed October 23, 2024. https:\/\/www.news-medical.net\/health\/History-of-COVID-19.aspx"},{"issue":"11","key":"2857_CR3","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","volume":"13","author":"MA Chowdhury","year":"2020","unstructured":"Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID-19: A review. J Infect Public Health. 2020;13(11):1619\u201329. https:\/\/doi.org\/10.1016\/j.jiph.2020.07.001.","journal-title":"J Infect Public Health"},{"issue":"10223","key":"2857_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, china: a descriptive study. Lancet. 2020;395(10223):507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7.","journal-title":"Lancet"},{"key":"2857_CR5","unstructured":"Coronavirus disease (COVID-19): How is it transmitted? Accessed October 23. 2024. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/coronavirus-disease-covid-19-how-is-it-transmitted"},{"key":"2857_CR6","unstructured":"CDC. Overview of Testing for SARS-CoV-2. COVID-19. August 30, 2024. Accessed October 23. 2024. https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/overview-testing-sars-cov-2.html"},{"key":"2857_CR7","unstructured":"CDC. Types of COVID-19 Treatment. COVID-19. October 3. 2024. Accessed October 23, 2024. https:\/\/www.cdc.gov\/covid\/treatment\/index.html"},{"key":"2857_CR8","unstructured":"CDC. Preventing Respiratory Viruses. Respiratory Illnesses. July 14. 2024. Accessed October 23, 2024. https:\/\/www.cdc.gov\/respiratory-viruses\/prevention\/index.html"},{"key":"2857_CR9","doi-asserted-by":"crossref","unstructured":"Realegeno S, Puschnik AS, Kumar A, et al. Monkeypox virus host factor screen using haploid cells identifies essential role of GARP complex in extracellular virus formation. J Virol. 2017;91(11). https:\/\/doi.org\/10.1128\/jvi.00011-17.","DOI":"10.1128\/JVI.00011-17"},{"issue":"2","key":"2857_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jama.2022.10802","volume":"328","author":"J Guarner","year":"2022","unstructured":"Guarner J, del Rio C, Malani PN. Monkeypox in 2022\u2014What clinicians need to know. JAMA. 2022;328(2):139\u201340. https:\/\/doi.org\/10.1001\/jama.2022.10802.","journal-title":"JAMA"},{"key":"2857_CR11","doi-asserted-by":"publisher","first-page":"102855","DOI":"10.1016\/j.jaut.2022.102855","volume":"131","author":"N Kumar","year":"2022","unstructured":"Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the Monkeypox virus. J Autoimmun. 2022;131:102855. https:\/\/doi.org\/10.1016\/j.jaut.2022.102855.","journal-title":"J Autoimmun"},{"issue":"1","key":"2857_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01675-2","volume":"8","author":"J Lu","year":"2023","unstructured":"Lu J, Xing H, Wang C, et al. Mpox (formerly monkeypox): pathogenesis, prevention and treatment. Sig Transduct Target Ther. 2023;8(1):1\u201315. https:\/\/doi.org\/10.1038\/s41392-023-01675-2.","journal-title":"Sig Transduct Target Ther"},{"key":"2857_CR13","unstructured":"Mpox. Accessed October 23, 2024. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/mpox"},{"issue":"5","key":"2857_CR14","first-page":"49","volume":"13","author":"R Mungmunpuntipantip","year":"2022","unstructured":"Mungmunpuntipantip R, Wiwanitkit V. Concurrent Monkeypox and COVID-19: role of interleukin-1 receptor antagonist-like protein mechanism. Int J Biochem Mol Biol. 2022;13(5):49.","journal-title":"Int J Biochem Mol Biol"},{"issue":"1","key":"2857_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s41983-022-00563-w","volume":"58","author":"T Roushdy","year":"2022","unstructured":"Roushdy T. SARS-CoV-2 and monkeypox: what is common and what is not in the present pandemic versus a potential one\u2014a neuropsychiatric narrative review. Egypt J Neurol Psychiatry Neurosurg. 2022;58(1):127. https:\/\/doi.org\/10.1186\/s41983-022-00563-w.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"issue":"4","key":"2857_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","volume":"53","author":"CC Lai","year":"2020","unstructured":"Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53(4):505\u201312. https:\/\/doi.org\/10.1016\/j.jmii.2020.05.013.","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"2857_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.medj.2021.06.007","volume":"2","author":"C Pawlowski","year":"2021","unstructured":"Pawlowski C, Lenehan P, Puranik A, et al. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. Med. 2021;2(8):979\u2013e9928. https:\/\/doi.org\/10.1016\/j.medj.2021.06.007.","journal-title":"Med"},{"issue":"10286","key":"2857_CR18","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0140-6736(21)00790-X","volume":"397","author":"VJ Hall","year":"2021","unstructured":"Hall VJ, Foulkes S, Saei A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021;397(10286):1725\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(21)00790-X.","journal-title":"Lancet"},{"issue":"10285","key":"2857_CR19","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0140-6736(21)00677-2","volume":"397","author":"E Vasileiou","year":"2021","unstructured":"Vasileiou E, Simpson CR, Shi T, et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in scotland: a National prospective cohort study. Lancet (London England). 2021;397(10285):1646. https:\/\/doi.org\/10.1016\/S0140-6736(21)00677-2.","journal-title":"Lancet (London England)"},{"key":"2857_CR20","doi-asserted-by":"publisher","unstructured":"Charles H, Thorley K, Turner C et al. Mpox Epidemiology and Vaccine Effectiveness, England, 2023 - Volume 30, Number 10\u2014October 2024 - Emerging Infectious Diseases journal - CDC. https:\/\/doi.org\/10.3201\/eid3010.240292","DOI":"10.3201\/eid3010.240292"},{"issue":"3","key":"2857_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s12519-022-00618-1","volume":"19","author":"YM Dou","year":"2022","unstructured":"Dou YM, Yuan H, Tian HW. Monkeypox virus: past and present. World J Pediatr. 2022;19(3):224. https:\/\/doi.org\/10.1007\/s12519-022-00618-1.","journal-title":"World J Pediatr"},{"issue":"2","key":"2857_CR22","doi-asserted-by":"publisher","first-page":"e34807","DOI":"10.7759\/cureus.34807","volume":"15","author":"A Kamal","year":"2023","unstructured":"Kamal A, Suppah M, Saadoun R, Yassin M. A comprehensive review of the current Monkeypox outbreak. Cureus. 2023;15(2):e34807. https:\/\/doi.org\/10.7759\/cureus.34807.","journal-title":"Cureus"},{"issue":"6","key":"2857_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.54026\/CREM\/1041","volume":"2","author":"W Knopp","year":"2022","unstructured":"Knopp W. Co-infection of COVID-19 and monkeypox: A case report from florida, USA, 2022. Curr Res Emerg Med. 2022;2(6):1\u20132. https:\/\/doi.org\/10.54026\/CREM\/1041.","journal-title":"Curr Res Emerg Med"},{"issue":"8","key":"2857_CR24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.acuroe.2024.05.011","volume":"48","author":"A Vives","year":"2024","unstructured":"Vives A, Mu\u00f1oz CA, Alonso-Tarres C, Cosentino M. Coinfection of monkeypox, COVID-19 and syphilis in a PrEP using MSM: a case report from Barcelona. Actas Urol Esp (Engl Ed). 2024;48(8):618\u20139. https:\/\/doi.org\/10.1016\/j.acuroe.2024.05.011.","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"2857_CR25","doi-asserted-by":"publisher","unstructured":"El-Qushayri AE, Reda A, Shah J. COVID-19 and Monkeypox co-infection: A rapid systematic review. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1094346.","DOI":"10.3389\/fimmu.2022.1094346"},{"key":"2857_CR26","doi-asserted-by":"publisher","first-page":"1052946","DOI":"10.3389\/fpubh.2023.1052946","volume":"11","author":"J Gao","year":"2023","unstructured":"Gao J, Zhou C, Liang H, et al. Monkeypox outbreaks in the context of the COVID-19 pandemic: network and clustering analyses of global risks and modified SEIR prediction of epidemic trends. Front Public Health. 2023;11:1052946. https:\/\/doi.org\/10.3389\/fpubh.2023.1052946.","journal-title":"Front Public Health"},{"key":"2857_CR27","doi-asserted-by":"publisher","first-page":"104197","DOI":"10.1016\/j.amsu.2022.104197","volume":"80","author":"O Uwishema","year":"2022","unstructured":"Uwishema O, Adekunbi O, Pe\u00f1amante CA, et al. The burden of Monkeypox virus amidst the Covid-19 pandemic in africa: A double battle for Africa. Annals Med Surg. 2022;80:104197. https:\/\/doi.org\/10.1016\/j.amsu.2022.104197.","journal-title":"Annals Med Surg"},{"key":"2857_CR28","unstructured":"Monkeypox. in the COVID-19 era| Journal of Ideas in Health. Accessed November 8, 2024. https:\/\/www.jidhealth.com\/index.php\/jidhealth\/article\/view\/231"},{"issue":"1","key":"2857_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-immunol-090222-110227","volume":"42","author":"B Hernaez","year":"2024","unstructured":"Hernaez B, Alcam\u00ed A. Poxvirus immune evasion. Annu Rev Immunol. 2024;42(1):551\u201384. https:\/\/doi.org\/10.1146\/annurev-immunol-090222-110227.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2857_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/pathogens10010006","volume":"10","author":"CD Suraweera","year":"2020","unstructured":"Suraweera CD, Hinds MG, Kvansakul M. Poxviral strategies to overcome host cell apoptosis. Pathogens. 2020;10(1):6. https:\/\/doi.org\/10.3390\/pathogens10010006.","journal-title":"Pathogens"},{"issue":"1","key":"2857_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000540815","volume":"16","author":"R Parnian","year":"2024","unstructured":"Parnian R, Heydarifard F, Mousavi FS, Heydarifard Z, Zandi M. Innate immune response to Monkeypox virus infection: mechanisms and immune escape. J Innate Immun. 2024;16(1):413\u201324. https:\/\/doi.org\/10.1159\/000540815.","journal-title":"J Innate Immun"},{"issue":"5","key":"2857_CR32","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.cellin.2024.100185","volume":"3","author":"XM Yi","year":"2024","unstructured":"Yi XM, Lei YL, Li M, Zhong L, Li S. The Monkeypox virus-host interplays. Cell Insight. 2024;3(5):100185. https:\/\/doi.org\/10.1016\/j.cellin.2024.100185.","journal-title":"Cell Insight"},{"key":"2857_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcv.2014.12.001","volume":"63","author":"SC Johnston","year":"2015","unstructured":"Johnston SC, Johnson JC, Stonier SW, et al. Cytokine modulation correlates with the severity of Monkeypox disease in humans. J Clin Virol. 2015;63:42\u20135. https:\/\/doi.org\/10.1016\/j.jcv.2014.12.001.","journal-title":"J Clin Virol"},{"key":"2857_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-031-57165-7_14","volume":"1451","author":"S Dwivedi","year":"2024","unstructured":"Dwivedi S, Singh V, Agrawal R, et al. Human Monkeypox virus and host immunity: new challenges in diagnostics and treatment strategies. Adv Exp Med Biol. 2024;1451:219\u201337. https:\/\/doi.org\/10.1007\/978-3-031-57165-7_14.","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"2857_CR35","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.3390\/v15122301","volume":"15","author":"FD Lucena-Neto","year":"2023","unstructured":"Lucena-Neto FD, Falc\u00e3o LFM, Vieira-Junior AS, et al. Monkeypox virus immune evasion and eye manifestation: beyond eyelid implications. Viruses. 2023;15(12):2301. https:\/\/doi.org\/10.3390\/v15122301.","journal-title":"Viruses"},{"issue":"5","key":"2857_CR36","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036\u2013e10459. https:\/\/doi.org\/10.1016\/j.cell.2020.04.026.","journal-title":"Cell"},{"issue":"6","key":"2857_CR37","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","volume":"27","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Ren L, Zhang L, et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020;27(6):883\u2013e8902. https:\/\/doi.org\/10.1016\/j.chom.2020.04.017.","journal-title":"Cell Host Microbe"},{"issue":"12","key":"2857_CR38","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.3390\/ijms25126427","volume":"25","author":"M Ranjbar","year":"2024","unstructured":"Ranjbar M, Cusack RP, Whetstone CE, et al. Immune response dynamics and biomarkers in COVID-19 patients. Int J Mol Sci. 2024;25(12):6427. https:\/\/doi.org\/10.3390\/ijms25126427.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2857_CR39","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1182\/blood-2007-01-071340","volume":"110","author":"S Phipps","year":"2007","unstructured":"Phipps S, Lam CE, Mahalingam S, et al. Eosinophils contribute to innate antiviral immunity and promote the clearance of respiratory syncytial virus. Blood. 2007;110(5):1578\u201386. https:\/\/doi.org\/10.1182\/blood-2007-01-071340.","journal-title":"Blood"},{"issue":"4","key":"2857_CR40","doi-asserted-by":"publisher","first-page":"e2020165","DOI":"10.23750\/abm.v91i4.10564","volume":"91","author":"AP Nair","year":"2020","unstructured":"Nair AP, Soliman A, Al Masalamani MA, et al. Clinical outcome of eosinophilia in patients with COVID-19: A controlled study. Acta Biomed. 2020;91(4):e2020165. https:\/\/doi.org\/10.23750\/abm.v91i4.10564.","journal-title":"Acta Biomed"},{"issue":"1","key":"2857_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/qjmed\/hcaa259","volume":"114","author":"E Roca","year":"2021","unstructured":"Roca E, Ventura L, Zattra CM, Lombardi C. EOSINOPENIA: an early, effective and relevant COVID-19 biomarker? QJM. 2021;114(1):68\u20139. https:\/\/doi.org\/10.1093\/qjmed\/hcaa259.","journal-title":"QJM"},{"issue":"23","key":"2857_CR42","doi-asserted-by":"publisher","first-page":"e26047","DOI":"10.1097\/MD.0000000000026047","volume":"100","author":"R Huang","year":"2021","unstructured":"Huang R, Xie L, He J, Dong H, Liu T. Association between the peripheral blood eosinophil counts and COVID-19: A meta-analysis. Med (Baltim). 2021;100(23):e26047. https:\/\/doi.org\/10.1097\/MD.0000000000026047.","journal-title":"Med (Baltim)"},{"issue":"3","key":"2857_CR43","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jaip.2021.12.034","volume":"10","author":"JG Zein","year":"2022","unstructured":"Zein JG, Strauss R, Attaway AH, et al. Eosinophilia is associated with improved COVID-19 outcomes in inhaled Corticosteroid-Treated patients. J Allergy Clin Immunol Pract. 2022;10(3):742\u2013e75014. https:\/\/doi.org\/10.1016\/j.jaip.2021.12.034.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"2857_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/08850666211037326","volume":"37","author":"W Xuan","year":"2022","unstructured":"Xuan W, Jiang X, Huang L, et al. Predictive value of eosinophil count on COVID-19 disease progression and outcomes, a retrospective study of Leishenshan hospital in wuhan, China. J Intensive Care Med. 2022;37(3):359\u201365. https:\/\/doi.org\/10.1177\/08850666211037326.","journal-title":"J Intensive Care Med"},{"issue":"3","key":"2857_CR45","doi-asserted-by":"publisher","first-page":"100521","DOI":"10.1016\/j.waojou.2021.100521","volume":"14","author":"B Yan","year":"2021","unstructured":"Yan B, Yang J, Xie Y, Tang X. Relationship between blood eosinophil levels and COVID-19 mortality. World Allergy Organ J. 2021;14(3):100521. https:\/\/doi.org\/10.1016\/j.waojou.2021.100521.","journal-title":"World Allergy Organ J"},{"issue":"1","key":"2857_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13568-023-01517-y","volume":"13","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Hetta HF, Alexiou A, Papadakis M, Batiha GES. Heparanase is the possible link between Monkeypox and Covid-19: robust candidature in the mystic and present perspective. AMB Express. 2023;13(1):13. https:\/\/doi.org\/10.1186\/s13568-023-01517-y.","journal-title":"AMB Express"},{"key":"2857_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12860-021-00395-1","volume":"22","author":"MFMG Wagner","year":"2021","unstructured":"Wagner MFMG, Theodoro TR, Filho CDASM, Oyafuso LKM, Pinhal MAS. Extracellular matrix alterations in the skin of patients affected by psoriasis. BMC Mol Cell Biology. 2021;22:55. https:\/\/doi.org\/10.1186\/s12860-021-00395-1.","journal-title":"BMC Mol Cell Biology"},{"issue":"38","key":"2857_CR48","doi-asserted-by":"publisher","first-page":"64344","DOI":"10.18632\/oncotarget.17834","volume":"8","author":"K Mayes","year":"2017","unstructured":"Mayes K, Elsayed Z, Alhazmi A, et al. BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. Oncotarget. 2017;8(38):64344\u201357. https:\/\/doi.org\/10.18632\/oncotarget.17834.","journal-title":"Oncotarget"},{"issue":"5","key":"2857_CR49","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1021\/acscentsci.1c01293","volume":"8","author":"SE Guimond","year":"2022","unstructured":"Guimond SE, Mycroft-West CJ, Gandhi NS, et al. Synthetic Heparan sulfate mimetic pixatimod (PG545) potently inhibits SARS-CoV-2 by disrupting the Spike-ACE2 interaction. ACS Cent Sci. 2022;8(5):527\u201345. https:\/\/doi.org\/10.1021\/acscentsci.1c01293.","journal-title":"ACS Cent Sci"},{"issue":"22","key":"2857_CR50","doi-asserted-by":"publisher","first-page":"2200424","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200424","volume":"27","author":"MP Duque","year":"2022","unstructured":"Duque MP, Ribeiro S, Martins JV, et al. Ongoing Monkeypox virus outbreak, portugal, 29 April to 23 May 2022. Eurosurveillance. 2022;27(22):2200424. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.22.2200424.","journal-title":"Eurosurveillance"},{"issue":"22","key":"2857_CR51","doi-asserted-by":"publisher","first-page":"2200421","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200421","volume":"27","author":"A Antinori","year":"2022","unstructured":"Antinori A, Mazzotta V, Vita S, et al. Epidemiological, clinical and virological characteristics of four cases of Monkeypox support transmission through sexual contact, italy, May 2022. Eurosurveillance. 2022;27(22):2200421. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.22.2200421.","journal-title":"Eurosurveillance"},{"issue":"2","key":"2857_CR52","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/cit703","volume":"58","author":"AM McCollum","year":"2014","unstructured":"McCollum AM, Damon IK. Human Monkeypox. Clin Infect Dis. 2014;58(2):260\u20137. https:\/\/doi.org\/10.1093\/cid\/cit703.","journal-title":"Clin Infect Dis"},{"key":"2857_CR53","unstructured":"Multi-country monkeypox outbreak: situation update. Accessed November 9. 2024. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON396"},{"issue":"4","key":"2857_CR54","doi-asserted-by":"publisher","first-page":"ytac123","DOI":"10.1093\/ehjcr\/ytac123","volume":"6","author":"F Perna","year":"2022","unstructured":"Perna F, Verecchia E, Pinnacchio G, Gerardino L, Brucato A, Manna R. Rapid resolution of severe pericardial effusion using Anakinra in a patient with COVID-19 vaccine-related acute pericarditis relapse: a case report. Eur Heart Journal: Case Rep. 2022;6(4):ytac123. https:\/\/doi.org\/10.1093\/ehjcr\/ytac123.","journal-title":"Eur Heart Journal: Case Rep"},{"issue":"1","key":"2857_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jfma.2022.08.014","volume":"122","author":"ST Huang","year":"2023","unstructured":"Huang ST, Wu YH, Lin HH, et al. The first imported case of Monkeypox in Taiwan. J Formos Med Assoc. 2023;122(1):73\u20137. https:\/\/doi.org\/10.1016\/j.jfma.2022.08.014.","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"2857_CR56","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jmii.2022.07.004","volume":"55","author":"CC Lai","year":"2022","unstructured":"Lai CC, Hsu CK, Yen MY, Lee PI, Ko WC, Hsueh PR. Monkeypox: an emerging global threat during the COVID-19 pandemic. J Microbiol Immunol Infect. 2022;55(5):787\u201394. https:\/\/doi.org\/10.1016\/j.jmii.2022.07.004.","journal-title":"J Microbiol Immunol Infect"},{"key":"2857_CR57","doi-asserted-by":"publisher","unstructured":"Sklenovsk\u00e1 N, Van Ranst M. Emergence of Monkeypox as the most important orthopoxvirus infection in humans. Front Public Health. 2018;6. https:\/\/doi.org\/10.3389\/fpubh.2018.00241.","DOI":"10.3389\/fpubh.2018.00241"},{"issue":"3","key":"2857_CR58","doi-asserted-by":"publisher","first-page":"e056549","DOI":"10.1136\/bmjopen-2021-056549","volume":"12","author":"K St\u00f8rdal","year":"2022","unstructured":"St\u00f8rdal K, Ruiz PLD, Greve-Isdahl M, et al. Risk factors for SARS-CoV-2 infection and hospitalisation in children and adolescents in norway: a nationwide population-based study. BMJ Open. 2022;12(3):e056549. https:\/\/doi.org\/10.1136\/bmjopen-2021-056549.","journal-title":"BMJ Open"},{"key":"2857_CR59","doi-asserted-by":"publisher","first-page":"105421","DOI":"10.1016\/j.jcv.2023.105421","volume":"161","author":"CK Lim","year":"2023","unstructured":"Lim CK, McKenzie C, Deerain J, et al. Correlation between Monkeypox viral load and infectious virus in clinical specimens. J Clin Virol. 2023;161:105421. https:\/\/doi.org\/10.1016\/j.jcv.2023.105421.","journal-title":"J Clin Virol"},{"issue":"2","key":"2857_CR60","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/v13020304","volume":"13","author":"H Tsukagoshi","year":"2021","unstructured":"Tsukagoshi H, Shinoda D, Saito M, et al. Relationships between viral load and the clinical course of COVID-19. Viruses. 2021;13(2):304. https:\/\/doi.org\/10.3390\/v13020304.","journal-title":"Viruses"},{"key":"2857_CR61","doi-asserted-by":"publisher","unstructured":"Presymptomatic viral shedding in high-risk mpox contacts: A prospective cohort study - Brosius\u2013\u20092023 - Journal of Medical Virology - Wiley Online Library. Accessed November 9. 2024. https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/jmv.28769","DOI":"10.1002\/jmv.28769"},{"issue":"5","key":"2857_CR62","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","volume":"26","author":"X He","year":"2020","unstructured":"He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672\u20135. https:\/\/doi.org\/10.1038\/s41591-020-0869-5.","journal-title":"Nat Med"},{"key":"2857_CR63","doi-asserted-by":"publisher","unstructured":"Estimation of monkeypox spread in a nonendemic country considering contact tracing and self-reporting: A stochastic modeling study - Ko\u2013\u20092023 - Journal of Medical Virology - Wiley Online Library. Accessed November 9. 2024. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/jmv.28232","DOI":"10.1002\/jmv.28232"},{"issue":"8","key":"2857_CR64","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1016\/S2468-2667(20)30157-2","volume":"5","author":"ME Kretzschmar","year":"2020","unstructured":"Kretzschmar ME, Rozhnova G, Bootsma MCJ, van Boven M, van de Wijgert JHHM, Bonten MJM. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study. Lancet Public Health. 2020;5(8):e452. https:\/\/doi.org\/10.1016\/S2468-2667(20)30157-2.","journal-title":"Lancet Public Health"},{"issue":"1","key":"2857_CR65","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/bab.2343","volume":"70","author":"M Zandi","year":"2023","unstructured":"Zandi M, Soltani S, Tabibzadeh A, et al. Partial sequence conservation of SARS-CoV-2 NSP-2, NSP-12, and Spike in stool samples from abadan, Iran. Biotechnol Appl Biochem. 2023;70(1):201\u20139. https:\/\/doi.org\/10.1002\/bab.2343.","journal-title":"Biotechnol Appl Biochem"},{"key":"2857_CR66","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.fraope.2024.100130","volume":"8","author":"GO Acheneje","year":"2024","unstructured":"Acheneje GO, Omale D, Atokolo W, Bolaji B. Modeling the transmission dynamics of the co-infection of COVID-19 and Monkeypox diseases with optimal control strategies and cost\u2013benefit analysis. Frankl Open. 2024;8:100130. https:\/\/doi.org\/10.1016\/j.fraope.2024.100130.","journal-title":"Frankl Open"},{"key":"2857_CR67","doi-asserted-by":"publisher","unstructured":"Induction of poxviral immunity by synthetic MVA-based dual-antigen COVID-19 vaccine COH04S1| medRxiv. Accessed November 8. 2024. https:\/\/www.medrxiv.org\/content\/https:\/\/doi.org\/10.1101\/2022.07.26.22277958v1","DOI":"10.1101\/2022.07.26.22277958v1"},{"issue":"1","key":"2857_CR68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s43856-024-00443-9","volume":"4","author":"F Chiuppesi","year":"2024","unstructured":"Chiuppesi F, Zaia JA, Gutierrez-Franco MA, et al. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against Mpox virus. Commun Med (Lond). 2024;4(1):19. https:\/\/doi.org\/10.1038\/s43856-024-00443-9.","journal-title":"Commun Med (Lond)"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02857-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:29:08Z","timestamp":1752139748000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02857-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2857"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02857-w","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent for participation"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors have approved the submitted version and have agreed both to be personally accountable for their contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which they are not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency statement"}},{"value":"Not commissioned, externally peer-reviewed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Provenance and peer review"}},{"value":"There is nothing to disclose.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}